Role of resistin in obesity, insulin resistance and Type II diabetes

Clinical Science

Volumn 109, Issue 3, 2005, Pages 243-256

  Kusminski, Christine M ^a   McTernan, Philip G ^a   Kumar, Sudhesh ^a  

^a UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

Adipocytokine; Inflammation; Insulin resistance; Obesity; Resistin; Type II diabetes

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ADRENALIN; ANGIOTENSINOGEN; BETA 3 ADRENERGIC RECEPTOR; CYSTEINE; DARGLITAZONE; ENDOTHELIN 1; GHRELIN; GLUCOSE; HYPOPHYSIS HORMONE; INSULIN; INTERLEUKIN 6; LEPTIN; LIPID; METFORMIN; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROPEPTIDE Y; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PIOGLITAZONE; RESISTIN; ROSIGLITAZONE; SEX HORMONE; STEROID HORMONE; THYROID HORMONE; TRANSFORMING GROWTH FACTOR BETA; TROGLITAZONE; TUMOR NECROSIS FACTOR ALPHA; UNINDEXED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

CARDIOVASCULAR DISEASE; GLUCOSE HOMEOSTASIS; GLUCOSE INTOLERANCE; HUMAN; INSULIN RESISTANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RISK FACTOR; TISSUE DISTRIBUTION;

AMINO ACID SEQUENCE; ANIMALS; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; HUMANS; INFLAMMATION; INSULIN RESISTANCE; MICE; MOLECULAR SEQUENCE DATA; OBESITY; RATS; SPECIES SPECIFICITY;

EID: 25144447626     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20050078     Document Type: Review

References (158)

1. Mohamed-Ali, V., Pinkney, J. H. and Coppack, S. W. (1998) Adipose tissue as an endocrine and paracrine organ. Int. J. Obes. Relat. Metab. Disord. 22, 1145-1158
2. Holcomb, I. N., Kabakoff, R. C., Chan, B. et al. (2000) FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family. EMBO J. 19, 4046-4055
3. Steppan, C. M., Bailey, S. T., Bhat, S. et al. (2001) The hormone resistin links obesity to diabetes. Nature (London) 409, 307-312
4. Kim, K. H., Lee, K., Moon, Y. S. and Sul, H. S. (2001) A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation. J. Biol. Chem. 276, 11252-11256
5. Banerjee, R. R. and Lazar, M. A. (2001) Dimerization of resistin and resistin-like molecules is determined by a single cysteine. J. Biol. Chem. 276, 25970-25973
6. Patel, S. D., Rajala, M. W., Rossetti, L., Scherer, P. E. and Shapiro, L. (2004) Bisulfide-dependent multimeric assembly of resistin family hormones. Science 304, 1154-1158
7. Steppan, C. M., Brown, E. J., Wright, C. M. et al. (2001) A family of tissue-specific resistin-like molecules. Proc. Natl. Acad. Sci. U.S.A. 98, 502-506
8. Gerstmayer, B., Kusters, D., Gebel, S. et al. (2003) Identification of RELM-γ, a novel resistin-like molecule with a distinct expression pattern. Genomics 81, 588-595
9. Rajala, M. W., Obici, S., Scherer, P. E. and Rossetti, L. (2003) Adipose-derived resistin and gut-derived resistin-like molecule-β selectively impair insulin action on glucose production. J. Clin. Invest. 111, 225-230
10. Stejskal, D., Proskova, J., Adamovska, S., Jurakova, R. and Bartek, J. (2002) Preliminary experience with resistin assessment in common population. Biomed. Pap. Med. Fac. Palacky. Univ., Olomouc. 146, 47-49
11. Azuma, K., Katsukawa, F., Oguchi, S. et al. (2003) Correlation between serum resistin level and adiposity in obese individuals. Obes. Res. 11, 997-1001
12. Valsamakis, G., McTernan, P. G., Chetty, R. et al. (2004) Modest weight loss and reduction in waist circumference after medical treatment are associated with favourable changes in serum adipocytokines. Metab. Clin. Exp. 53, 430-434
13. Nagaev, I. and Smith, U. (2001) Insulin resistance and type 2 diabetes are not related to resistin expression in human fat cells or skeletal muscle. Biochem. Biophys. Res. Commun. 285, 561-564
14. Janke, J., Engeli, S., Gorzelniak, K., Luft, F. C. and Sharma, A. M. (2002) Resistin gene expression in human adipocytes is not related to insulin resistance. Obes. Res. 10, 1-5
15. Savage, D. B., Sewter, C. P., Klenk, E. S. et al. (2001) Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 50, 2199-2202
16. McTernan, C. L., McTernan, P. G., Harte, A. L., Levick, P. L., Barnett, A. H. and Kumar, S. (2002) Resistin, central obesity, and type 2 diabetes. Lancet 359, 46-47
17. Patel, L., Buckels, A. C., Kinghorn, I. J. et al. (2003) Resistin is expressed in human macrophages and directly regulated by PPARγ activators. Biochem. Biophys. Res. Commun. 300, 472-476
18. Fain, J. N., Cheema, P. S., Bahouth, S. W. and Lloyd Hiler, M. (2003) Resistin release by human adipose tissue explants in primary culture. Biochem. Biophys. Res. Commun. 300, 674-678
19. Nohira, T., Nagao, K., Kameyama, K. et al. (2004) Identification of an alternative splicing transcript for the resistin gene and distribution of its mRNA in human tissue. Eur. J. Endocrinol. 151, 151-154
20. Del Arco, A., Peralta, S., Carrascosa, J. M., Ros, M., Andres, A. and Arribas, C. (2003) Alternative splicing generates a novel non-secretable resistin isoform in Wistar rats. FEBS Lett. 555, 243-249
21. Steppan, C. M. and Lazar, M. A. (2004) The current biology of resistin. J. Intern. Med. 255, 439-447
22. Ghosh, S., Singh, A. K., Aruna, B., Mukhopadhyay, S. and Ehtesham, N. Z. (2003) The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene 305, 27-34
23. Gabriely, I., Ma, X. H., Yang, X. M. et al. (2002) Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process? Diabetes 51, 2951-2958
24. Levy, J. R., Davenport, B., Clore, J. N. and Stevens, W. (2002) Lipid metabolism and resistin gene expression in insulin-resistant Fischer 344 rats. Am. J. Physiol. Endocrinol. Metab. 282, E626-E633
25. McTernan, P. G., McTernan, C. L., Chetty, R. et al. (2002) Increased resistin gene and protein expression in human abdominal adipose tissue. J. Clin. Endocrinol. Metab. 87, 2407
26. Zhang, J., Qin, Y., Zheng, X. et al. (2002) The relationship between human serum resistin level and body fat content, plasma glucose as well as blood pressure. Zhonghua Yi Xue Za Zhi 82, 1609-1612
27. Way, J. M., Gorgun, C. Z., Tong, Q. et al. (2001) Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor γ agonists. J. Biol. Chem. 276, 25651-25653
28. Fukui, Y. and Motojima, K. (2002) Expression of resistin in the adipose tissue is modulated by various factors including peroxisome proliferator- activated receptor α. Diabetes Obes. Metab. 4, 342-345
29. Rajala, M. W., Lin, Y., Ranalletta, M. et al. (2002) Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-α in adipose tissue. Mol. Endocrinol. 16, 1920-1930
30. Steppan, C. M. and Lazar, M. A. (2002) Resistin and obesity-associated insulin resistance. Trends Endocrinol. Metab. 13, 18-23
31. Makimura, H., Mizuno, T. M., Bergen, H. and Mobbs, C. V. (2002) Adiponectin is stimulated by adrenalectomy in ob/ob mice and is highly correlated with resistin mRNA. Am. J. Physiol. Endocrinol. Metab. 283, E1266-E1271
32. Le Lay, S., Boucher, J., Rey, A. et al. (2001) Decreased resistin expression in mice with different sensitivities to a high-fat diet. Biochem. Biophys. Res. Commun. 289, 564-567
33. Lee, J. H., Bullen, Jr, J. W., Stoyneva, V. L. and Mantzoros, C. S. (2005) Circulating resistin in lean, obese and insulin-resistant mouse models: lack of association with insulinemia and glycemia. Am. J. Physiol. Endocrinol. Metab. 288, E625-E632
34. Rajala, M. W., Qi, Y., Patel, H. R. et al. (2004) Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 53, 1671-1679
35. Asensio, C., Cettour-Rose, P., Theander-Carrillo, C., Rohner-Jeanrenaud, F. and Muzzin, P. (2004) Changes in glycemia by leptin administration or high-fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis. Endocrinology 145, 2206-2213
36. Haugen, F., Jorgensen, A., Drevon, C. A. and Trayhurn, P. (2001) Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes. FEBS Lett. 507, 105-108
37. Kim, K. H., Zhao, L., Moon, Y., Kang, C. and Sul, H. S. (2004) Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc. Natl. Acad. Sci. U.S.A. 101, 6780-6785
38. Vendrell, J., Broch, M., Vilarrasa, N. et al. (2004) Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity. Obes. Res. 12, 962-971
39. Schaffler, A., Buchler, C., Muller-Ladner, U. et al. (2004) Identification of variables influencing resistin serum levels in patients with type 1 and type 2 diabetes mellitus. Horm. Metab. Res. 36, 702-707
40. Degawa-Yamauchi, M., Bovenkerk, J. E., Juliar, B. E. et al. (2003) Serum resistin (FIZZ3) protein is increased in obese humans. J. Clin. Endocrinol. Metab. 88, 5452-5455
41. Vozarova de Courten, B., Degawa-Yamauchi, M., Considine, R. V., Tataranni, P. A. and Volarova de Courten, B. (2004) High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians. Diabetes 53, 1279-1284
42. Yannakoulia, M., Yiannakouris, N., Bluher, S., Matalas, A. L., Klimis-Zacas, D. and Mantzoros, C. S. (2003) Body fat mass and macronutrient intake in relation to circulating soluble leptin receptor, free leptin index, adiponectin, and resistin concentrations in healthy humans. J. Clin. Endocrinol. Metab. 88, 1730-1736
43. McTernan, P. G., Fisher, F. M., Valsamakis, G. et al. (2003) Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid and glucose metabolism in human differentiated adipocytes. J. Clin. Endocrinol. Metab. 88, 6098-6106
44. Maebuchi, M., Machidori, M., Urade, R., Ogawa, T. and Moriyama, T. (2003) Low resistin levels in adipose tissues and serum in high-fat fed mice and genetically obese mice: development of an ELISA system for quantification of resistin. Arch. Biochem. Biophys. 416, 164-170
45. Huang, L., Wang, Z. and Li, C. (2001) Modulation of circulating leptin levels by its soluble receptor. J. Biol. Chem. 276, 6343-6349
46. Lahlou, N., Clement, K., Carel, J. C. et al. (2000) Soluble leptin receptor in serum of subjects with complete resistance to leptin: relation to fat mass. Diabetes 49, 1347-1352
47. Winkler, G., Kiss, S., Keszthelyi, L. et al. (2003) Expression of tumor necrosis factor (TNF)-α protein in the subcutaneous and visceral adipose tissue in correlation with adipocyte cell volume, serum TNF-α, soluble serum TNF-receptor-2 concentrations and C-peptide level. Eur. J. Endocrinol. 149, 129-135
48. Lee, J. H., Chan, J. L., Yiannakouris, N. et al. (2003) Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects. J. Clin. Endocrinol. Metab. 88, 4848-4856
49. Silha, J. V., Krsek, M., Skrha, J. V., Sucharda, P., Nyomba, B. L. and Murphy, L. J. (2003) Plasma resistin, adiponectin and leptin levels in lean and obese subjects: correlations with insulin resistance. Eur. J. Endocrinol. 149, 331-335
50. Heilbronn, L. K., Rood, J., Janderova, L. et al. (2004) Relationship between serum resistin concentrations and insulin resistance in nonobese, obese, and obese diabetic subjects. J. Clin. Endocrinol. Metab. 89, 1844-1848
51. Smith, S. R., Bai, F., Charbonneau, C., Janderova, L. and Argyropoulos, G. (2003) A promoter genotype and oxidative stress potentially link resistin to human insulin resistance. Diabetes 52, 1611-1618
52. Fujinami, A., Obayashi, H., Ohta, K. et al. (2004) Enzyme-linked immunosorbent assay for circulating human resistin: resistin concentrations in normal subjects and patients with type 2 diabetes. Clin. Chim. Acta. 339, 57-63
53. Pfutzner, A., Langenfeld, M., Kunt, T., Lobig, M. and Forst, T. (2003) Evaluation of human resistin assays with serum from patients with type 2 diabetes and different degrees of insulin resistance. Clin. Lab. 49, 571-576
54. Youn, B. S., Yu, K. Y., Park, H. J. et al. (2004) Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus. J. Clin. Endocrinol. Metab. 89, 150-156
55. Yang, J., Li, M., Wu, C. Y., Wang, H., Xu, Q. S. and Deng, J. Y. (2003) Reduced resistin levels in patients with type 2 diabetes mellitus. Zhonghua Yi Xue Za Zhi 83, 1471-1474
56. Hirosumi, J., Tuncman, G., Chang, L. et al. (2002) A central role for JNK in obesity and insulin resistance. Nature (London) 420, 333-336
57. Juan, C. C., Au, L. C., Fang, V. S. et al. (2001) Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem. Biophys. Res. Commun. 289, 1328-1333
58. Stejskal, D., Adamovska, S., Bartek, J., Jurakova, R. and Proskova, J. (2003) Resistin concentrations in persons with type 2 diabetes mellitus and in individuals with acute inflammatory disease. Biomed. Pap. Med. Fac. Palacky. Univ., Olomouc. 147, 63-69
59. Hegele, R. A., Kraw, M. E., Ban, M. R., Miskie, B. A., Huff, M. W. and Cao, H. (2003) Elevated serum C-reactive protein and free fatty acids among nondiabetic carriers of missense mutations in the gene encoding lamin A/C (LMNA) with partial lipodystrophy. Arterioscler., Thromb., Vasc. Biol. 23, 111-116
60. Moon, B., Kwan, J. J., Duddy, N., Sweeney, G. and Begum, N. (2003) Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am. J. Physiol. Endocrinol. Metab. 285, E106-E115
61. Steppan, C. M., Wang, J., Whiteman, E. L., Birnbaum, M. J. and Lazar, M. A. (2005) Activation of SOCS-3 by resistin. Mol. Cell. Biol. 25, 1569-1575
62. Banerjee, R. R., Rangwala, S. M., Shapiro, J. S. et al. (2004) Regulation of fasted blood glucose by resistin. Science 303, 1195-1198
63. Rangwala, S. M., Rich, A. S., Rhoades, B. et al. (2004) Abnormal glucose homeostasis due to chronic hyperresistinemia. Diabetes. 53, 1937-1941
64. Moore, G. B., Chapman, H., Holder, J. C. et al. (2001) Differential regulation of adipocytokine mRNAs by rosiglitazone in db/db mice. Biochem. Biophys. Res. Commun. 286, 735-741
65. Shojima, N., Sakoda, H., Ogihara, T. et al. (2002) Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 51, 1737-1744
66. Fujita, H., Fujishima, H., Morii, T. et al. (2002) Effect of metformin on adipose tissue resistin expression in db/db mice. Biochem. Biophys. Res. Commun. 298, 345-349
67. Bajaj, M., Suraamornkul, S., Hardies, L. J., Pratipanawatr, T. and DeFronzo, R. A. (2004) Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int. J. Obes. Relat. Metab. Disord. 28, 783-789
68. Lehrke, M., Reilly, M. P., Millington, S. C., Iqbal, N., Rader, D. J. and Lazar, M. A. (2004) An inflammatory cascade leading to hyperresistinemia in humans. PLoS Med. 1, e45
69. Aranda, A. and Pascual, A. (2001) Nuclear hormone receptors and gene expression. Physiol. Rev. 81, 1269-1304
70. Ricote, M., Li, A. C., Willson, T. M., Kelly, C. J. and Glass, C. K. (1998) The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature (London) 391, 79-82
71. Hong, G., Davis, B., Khatoon, N., Baker, S. F. and Brown, J. (2003) PPAR γ-dependent anti-inflammatory action of rosiglitazone in human monocytes: suppression of TNF α secretion is not mediated by PTEN regulation. Biochem. Biophys. Res. Commun. 303, 782-787
72. Nogueiras, R., Gallego, R., Gualillo, O. et al. (2003) Resistin is expressed in different rat tissues and is regulated in a tissue- and gender-specific manner. FEBS Lett. 548, 21-27
73. Nogueiras, R., Gualillo, O., Caminos, J. E., Casanueva, F. F. and Dieguez, C. (2003) Regulation of resistin by gonadal, thyroid hormone, and nutritional status. Obes. Res. 11, 408-414
74. Gui, Y., Silha, J. V. and Murphy, L. J. (2004) Sexual dimorphism and regulation of resistin, adiponectin, and leptin expression in the mouse. Obes. Res. 12, 1481-1491
75. Hu, E., Liang, P. and Spiegelman, B. M. (1996) AdipoQ is a novel adipose-specific gene dysregulated in obesity. J. Biol. Chem. 271, 10697-10703
76. Weyer, C., Funahashi, T., Tanaka, S. et al. (2001) Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J. Clin. Endocrinol. Metab. 86, 1930-1935
77. Yang, W. S., Lee, W. J., Funahashi, T. et al. (2001) Weight reduction increases plasma levels of an adipose-derived anti-inflammatory protein, adiponectin. J. Clin. Endocrinol Metab. 86, 3815-3819
78. Spranger, J., Kroke, A., Mohlig, M. et al. (2003) Adiponectin and protection against type 2 diabetes mellitus. Lancet 361, 226-228
79. Yu, J. G., Javorschi, S., Hevener, A. L. et al. (2002) The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects. Diabetes 51, 2968-2974
80. Motoshima, H., Wu, X., Sinha, M. K. et al. (2002) Differential regulation of adiponectin secretion from cultured human omental and subcutaneous adipocytes: effects of insulin and rosiglitazone. J. Clin. Endocrinol. Metab. 87, 5662-5667
81. Yang, W. S., Jeng, C. Y., Wu, T. J. et al. (2002) Synthetic peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients. Diabetes Care 25, 376-380
82. Delporte, M. L., Funahashi, T., Takahashi, M., Matsuzawa, Y. and Brichard, S. M. (2002) Pre- and post-translational negative effect of β-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochem. J. 367, 677-685
83. Fasshauer, M., Kralisch, S., Klier, M. et al. (2003) Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 301, 1045-1050
84. Dandona, P., Aljada, A. and Bandyopadhyay, A. (2004) Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 25, 4-7
85. Fernandez-Real, J. M. and Ricart, W. (2003) Insulin resistance and chronic cardiovascular inflammatory syndrome. Endocr. Rev. 24, 278-301
86. Lu, S. C., Shieh, W. Y., Chen, C. Y., Hsu, S. C. and Chen, H. L. (2002) Lipopolysaccharide increases resistin gene expression in vivo and in vitro. FEBS Lett. 530, 158-162
87. Harsch, I. A., Koebnick, C., Wallaschofski, H. et al. (2004) Resistin levels in patients with obstructive sleep apnoea syndrome: the link to subclinical inflammation? Med. Sci. Monit. 10, CR510-CR515
88. Kaser, S., Kaser, A., Sandhofer, A., Ebenbichler, C. F., Tilg, H. and Patsch, J. R. (2003) Resistin messenger-RNA expression is increased by pro-inflammatory cytokines in vitro. Biochem. Biophys. Res. Commun. 309, 286-290
89. Wellen, K. E. and Hotamisligil, G. S. (2003) Obesity-induced inflammatory changes in adipose tissue. J. Clin. Invest. 112, 1785-1788
90. Charriere, G., Cousin, B., Arnaud, E. et al. (2003) Preadipocyte conversion to macrophage. Evidence of plasticity. J. Biol. Chem. 278, 9850-9855
91. Rajala, M. W. and Scherer, P. E. (2003) The adipocyte: at the crossroads of energy homeostasis, inflammation, and atherosclerosis. Endocrinology 144, 3765-3773
92. Haffner, S. M. (2003) Insulin resistance, inflammation, and the prediabetic state. Am. J. Cardiol. 92, 18J-26J
93. Wulster-Radcliffe, M. C., Ajuwon, K. M., Wang, J., Christian, J. A. and Spurlock, M. E. (2004) Adiponectin differentially regulates cytokines in porcine macrophages. Biochem. Biophys. Res. Commun. 316, 924-929
94. Yokota, T., Oritani, K., Takahashi, I. et al. (2000) Adiponectin, a new member of the family of soluble defense collagens, negatively regulates the growth of myelomonocytic progenitors and the functions of macrophages. Blood 96, 1723-1732
95. Jhun, B. S., Jin, Q., Oh, Y. T. et al. (2004) 5-Aminoimidazole-4- carboxamide riboside suppresses lipopolysaccharide-induced TNF-α production through inhibition of phosphatidylinositol 3-kinase/Akt activation in RAW 264.7 murine macrophages. Biochem. Biophys. Res. Commun. 318, 372-380
96. Ajuwon, K. M. and Spurlock, M. E. (2005) Adiponectin inhibits LPS-induced NFκB activation and IL-6 production, and increases PPARγ2 expression in adipocytes. Am. J. Physiol. Regulatory Integrative Comp. Physiol. 288, R1220-R1225
97. Cooke, J. P. and Oka, R. K. (2002) Does leptin cause vascular disease? Circulation 106, 1904-1905
98. Reilly, M. P., Lehrke, M., Wolfe, M. L., Rohatgi, A., Lazar, M. A. and Rader, D. J. (2005) Resistin is an inflammatory marker of atherosclerosis in humans. Circulation 111, 932-939
99. Verma, S., Li, S. H., Wang, C. H. et al. (2003) Resistin promotes endothelial cell activation: further evidence of adipokine-endothelial interaction. Circulation 108, 736-740
100. Kawanami, D., Maemura, K., Takeda, N. et al. (2004) Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions. Biochem. Biophys. Res. Commun. 314, 415-419
101. Rolph, M. S., Zimmer, S., Bottazzi, B., Garlanda, C., Mantovani, A. and Hansson, G. K. (2002) Production of the long pentraxin PTX3 in advanced atherosclerotic plaques. Arterioscler., Thromb., Vasc. Biol. 22, e10-e14
102. Libby, P. (2002) Inflammation in atherosclerosis. Nature (London) 420, 868-874
103. Hotta, K., Funahashi, T., Arita, Y. et al. (2000) Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler., Thromb., Vasc. Biol. 20, 1595-1599
104. Engert, J. C., Vohl, M. C., Williams, S. M. et al. (2002) 5′ flanking variants of resistin are associated with obesity. Diabetes 51, 1629-1634
105. Mattevi, V. S., Zembrzuski, V. M. and Hutz, M. H. (2004) A resistin gene polymorphism is associated with body mass index in women. Hum. Genet. 115, 208-212
106. Osawa, H., Yamada, K., Onuma, H. et al. (2004) The G/G genotype of a resistin single-nucleotide polymorphism at - 420 increases type 2 diabetes mellitus susceptibility by inducing promoter activity through specific binding of Sp1/3. Am. J. Hum. Genet. 75, 678-686
107. Ma, X., Warram, J. H., Trischitta, V. and Doria, A. (2002) Genetic variants at the resistin locus and risk of type 2 diabetes in Caucasians. J. Clin. Endocrinol. Metab. 87, 4407-4410
108. Pizzuti, A., Argiolas, A., Di Paola, R. et al. (2002) An ATG repeat in the 3′-untranslated region of the human resistm gene is associated with a decreased risk of insulin resistance. J. Clin. Endocrinol. Metab. 87, 4403-4406
109. Azuma, K., Oguchi, S., Matsubara, Y. et al. (2004) Novel resistin promoter polymorphisms: association with serum resistin level in Japanese obese individuals. Horm. Metab. Res. 36, 564-570
110. Osawa, H., Onuma, H., Murakami, A. et al. (2002) Systematic search for single nucleotide polymorphisms in the resistin gene: the absence of evidence for the association of three identified single nucleotide polymorphisms with Japanese type 2 diabetes. Diabetes 51, 863-866
111. Ochi, M., Osawa, H., Onuma, H. et al. (2003) The absence of evidence for major effects of the frequent SNP + 299G > A in the resistin gene on susceptibility to insulin resistance syndrome associated with Japanese type 2 diabetes. Diabetes Res. Clin. Pract. 61, 191-198
112. Montague, C. T., Prins, J. B., Sanders, L., Digby, J. E. and O'Rahilly, S. (1997) Depot- and sex-specific differences in human leptin mRNA expression: implications for the control of regional fat distribution. Diabetes 46, 342-347
113. Lonnqvist, F., Nordfors, L., Jansson, M., Thorne, A., Schalling, M. and Arner, P. (1997) Leptin secretion from adipose tissue in women. Relationship to plasma levels and gene expression. J. Clin. Invest. 99, 2398-2404
114. Kim, Y. W. and Scarpace, P. J. (2003) Repeated fasting/refeeding elevates plasma leptin without increasing fat mass in rats. Physiol. Behav. 78, 459-464
115. Hube, F. and Hauner, H. (1999) The role of TNF-α in human adipose tissue: prevention of weight gain at the expense of insulin resistance? Horm. Metab. Res. 31, 626-631
116. Grossi, S. G. (2001) Treatment of periodontal disease and control of diabetes: an assessment of the evidence and need for future research. Ann. Periodontol. 6, 138-145
117. Fruhbeck, G., Gomez-Ambrosi, J., Muruzabal, F. J. and Burrell, M. A. (2001) The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. Endocrinol. Metab. 280, E827-E847
118. Bullo, M., Garcia-Lorda, P., Peinado-Onsurbe, J. et al. (2002) TNF-α expression of subcutaneous adipose tissue in obese and morbid obese females: relationship to adipocyte LPL activity and leptin synthesis. Int. J. Obes. Relat. Metab. Disord. 26, 652-658
119. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L. and Spiegelman, B. M. (1995) Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415
120. Hotamisligil, G. S., Shargill, N. S. and Spiegelman, B. M. (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 259, 87-91
121. Mohamed-Ali, V., Goodrick, S., Rawesh, A. et al. (1997) Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-α, in vivo. J. Clin. Endocrinol. Metab. 82, 4196-4200
122. Xing, Z., Gauldie, J., Cox, G. et al. (1998) IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101, 311-320
123. Krogh-Madsen, R., Moller, K., Dela, F., Kronborg, G., Jauffred, S. and Pedersen, B. K. (2004) Effect of hyperglycemia and hyperinsulinemia on the response of IL-6, TNF-α, and FFAs to low-dose endotoxemia in humans. Am. J. Physiol. Endocrinol. Metab. 286, E766-E772
124. Febbraio, M. A. and Pedersen, B. K. (2002) Muscle-derived interleukin-6: mechanisms for activation and possible biological roles. FASEB J. 16, 1335-1347
125. Ostrowski, S. R., Plomgaard, P., Fischer, C. P. et al. (2005) Interleukin-6 infusion during human endotoxaemia inhibits in vitro release of the urokinase receptor from peripheral blood mononuclear cells. Scand. J. Immunol. 61, 197-206
126. Juhan-Vague, I. and Alessi, M. C. (1997) PAI-1, obesity, insulin resistance and risk of cardiovascular events. Thromb. Haemostasis 78, 656-660
127. Van Harmelen, V., Ariapart, P., Hoffstedt, J., Lundkvist, I., Bringman, S. and Arner, P. (2000) Increased adipose angiotensinogen gene expression in human obesity. Obes. Res. 8, 337-341
128. Fried, S. K. and Kral, J. G. (1987) Sex differences in regional distribution of fat cell size and lipoprotein lipase activity in morbidly obese patients. Int. J. Obes. 11, 129-140
129. Fruebis, J., Tsao, T. S., Javorschi, S. et al. (2001) Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc. Natl. Acad. Sci. U.S.A. 98, 2005-2010
130. Arita, Y., Kihara, S., Ouchi, N. et al. (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem. Biophys. Res. Commun. 257, 79-83
131. Fisher, F. M., McTernan, P. G., Valsamakis, G. et al. (2002) Differences in adiponectin protein expression: effect of fat depots and type 2 diabetic status. Horm. Metab. Res. 34, 650-654
132. Samad, F. and Loskutoff, D. J. (1996) Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol. Med. 2, 568-582
133. Montague, C. T., Prins, J. B., Sanders, L. et al. (1998) Depot-related gene expression in human subcutaneous and omental adipocytes. Diabetes 47, 1384-1391
134. Lefebvre, A. M., Laville, M., Vega, N. et al. (1998) Depot-specific differences in adipose tissue gene expression in lean and obese subjects. Diabetes 47, 98-103
135. Faraj, M., Lu, H. L. and Cianflone, K. (2004) Diabetes, lipids, and adipocyte secretagogues. Biochem. Cell. Biol. 82, 170-190
136. Kojima, M., Hosoda, H., Date, Y., Nakazato, M., Matsuo, H. and Kangawa, K. (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature (London) 402, 656-660
137. Tschop, M., Smiley, D. L. and Heiman, M. L. (2000) Ghrelin induces adiposity in rodents. Nature (London) 407, 908-913
138. Tschop, M., Weyer, C., Tataranni, P. A., Devanarayan, V., Ravussin, E. and Heiman, M. L. (2001) Circulating ghrelin levels are decreased in human obesity. Diabetes 50, 707-709
139. Wren, A. M., Small, C. J., Ward, H. L. et al. (2000) The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141, 4325-4328
140. Poykko, S. M., Kellokoski, E., Horkko, S., Kauma, H., Kesaniemi, Y. A. and Ukkola, O. (2003) Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52, 2546-2553
141. Baulande, S., Lasnier, F., Lucas, M. and Pairault, J. (2001) Adiponutrin, a transmembrane protein corresponding to a novel dietary- and obesity-linked mRNA specifically expressed in the adipose lineage. J. Biol. Chem. 276, 33336-33344
142. Polson, D. A. and Thompson, M. P. (2003) Adiponutrin mRNA expression in white adipose tissue is rapidly induced by meal-feeding a high-sucrose diet. Biochem. Biophys. Res. Commun. 301, 261-266
143. Liu, Y. M., Moldes, M., Bastard, J. P. et al. (2004) Adiponutrin: a new gene regulated by energy balance in human adipose tissue. J. Clin. Endocrinol. Metab. 89, 2684-2689
144. Atzmon, G., Yang, X. M., Muzumdar, R., Ma, X. H., Gabriely, I. and Barzilai, N. (2002) Differential gene expression between visceral and subcutaneous fat depots. Horm. Metab. Res. 34, 622-628
145. Morash, B. A., Ur, E., Wiesner, G., Roy, J. and Wilkinson, M. (2004) Pituitary resistin gene expression: effects of age, gender and obesity. Neuroendocrinology 79, 149-156
146. Morash, B. A., Willkinson, D., Ur, E. and Wilkinson, M. (2002) Resistin expression and regulation in mouse pituitary. FEBS Lett. 526, 26-30
147. Milan, G., Granzotto, M., Scarda, A. et al. (2002) Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss. Obes. Res. 10, 1095-1103
148. Dietze, D., Koenen, M., Rohrig, K., Horikoshi, H., Hauner, H. and Eckel, J. (2002) Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 51, 2369-2376
149. Minn, A. H., Patterson, N. B., Pack, S. et al. (2003) Resistin is expressed in pancreatic islets. Biochem. Biophys. Res. Commun. 310, 641-645
150. Yura, S., Sagawa, N., Itoh, H. et al. (2003) Resistin is expressed in the human placenta. J. Clin. Endocrinol. Metab. 88, 1394-1397
151. Delhanty, P. J., Mesotten, D., McDougall, F. and Baxter, R. C. (2002) Growth hormone rapidly induces resistin gene expression in white adipose tissue of spontaneous dwarf (SDR) rats. Endocrinology 143, 2445-2448
152. Ling, C., Kindblom, J., Wennbo, H. and Billig, H. (2001) Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels. FEBS Lett. 507, 147-150
153. Kochan, Z. and Karbowska, J. (2004) Dehydroepiandrosterone up-regulates resistin gene expression in white adipose tissue. Mol. Cell. Endocrinol. 218, 57-64
154. Huang, S. W., Seow, K. M., Ho, L. T. et al. (2005) Resistin mRNA levels are downregulated by estrogen in vivo and in vitro. FEBS Lett. 579, 449-454
155. Iglesias, P., Alvarez Fidalgo, P., Codoceo, R. and Diez, J. J. (2003) Serum concentrations of adipocytokines in patients with hyperthyroidism and hypothyroidism before and after control of thyroid function. Clin. Endocrinol. 59, 621-629
156. Yuzuriha, H., Inui, A., Goto, K., Asakawa, A., Fujimiya, M. and Kasuga, M. (2003) Intracerebroventricular administration of NPY stimulates resistin gene expression in mice. Int. J. Mol. Med. 11, 675-676
157. S-protein-coupled pathway in 3T3-L1 adipocytes. FEBS Lett. 500, 60-63
158. Zhong, Q., Lin, C. Y., Clarke, K. J., Kemppainen, R. J., Schwartz, D. D. and Judd, R. L. (2002) Endothelin-1 inhibits resistin secretion in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 296, 383-387